-
20241
-
20242
The Relationship between Simple Snoring and Metabolic Syndrome: A Cross-Sectional Study
Published 2019-01-01Get full text
Article -
20243
-
20244
Characterization of an IncR Plasmid with Two Copies of ISCR-Linked qnrB6 from ST968 Klebsiella pneumoniae
Published 2020-01-01Get full text
Article -
20245
Unleashing the potential of a low CpG Passer transposon for superior CAR-T cell therapy
Published 2025-02-01Get full text
Article -
20246
-
20247
-
20248
Scalable preparation of furanosteroidal viridin, β-viridin and viridiol from Trichoderma virens
Published 2025-01-01Get full text
Article -
20249
-
20250
Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a Prospective and Randomized Early Bactericidal Activity Study
Published 2025-01-01“…Guanglu Jiang,1,* Rongmei Liu,2,* Yi Xue,1 Qiping Ge,2 Lihui Nie,2 Zizheng Lv,2 Zhongshun Kong,2 Jin Shi,2 Hongmei Chen,2 Hua Li,2 Xiaoguang Wu,2 Li Xie,2 Yanhua Song,2 Hairong Huang,1 Mengqiu Gao2 1National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Mengqiu Gao; Hairong Huang, Email gaomqwdm@aliyun.com; huanghairong@tb123.orgBackground: Contezolid (CZD) is an analog of Linezolid (LZD) that has demonstrated potent in vitro and in vivo activity against tuberculosis (TB) while presenting a safer side-effect profile. …”
Get full text
Article -
20251
-
20252
Effects of biological agents on rhizosphere microecological environment and nutrient availability for rice
Published 2025-01-01Get full text
Article -
20253
-
20254
An Age-Related Hearing Protection Locus on Chromosome 16 of BXD Strain Mice
Published 2020-01-01Get full text
Article -
20255
-
20256
-
20257
Purine metabolites regulate leukemic cell sensitivity toward cytarabine
Published 2025-01-01Get full text
Article -
20258
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.
Published 2024-12-01Get full text
Article -
20259
-
20260